These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 20177796)
21. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance. van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640 [TBL] [Abstract][Full Text] [Related]
22. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer]. Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822 [TBL] [Abstract][Full Text] [Related]
23. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma]. Zhang C; Cui GH; Liu F; Wu QL; Chen Y Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309 [TBL] [Abstract][Full Text] [Related]
24. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer. Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302 [TBL] [Abstract][Full Text] [Related]
25. The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma. Almofti A; Uchida D; Begum NM; Tomizuka Y; Iga H; Yoshida H; Sato M Int J Oncol; 2004 Jul; 25(1):65-71. PubMed ID: 15201990 [TBL] [Abstract][Full Text] [Related]
26. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies. Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206 [TBL] [Abstract][Full Text] [Related]
27. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Schimanski CC; Schwald S; Simiantonaki N; Jayasinghe C; Gönner U; Wilsberg V; Junginger T; Berger MR; Galle PR; Moehler M Clin Cancer Res; 2005 Mar; 11(5):1743-50. PubMed ID: 15755995 [TBL] [Abstract][Full Text] [Related]
28. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases. Yopp AC; Shia J; Butte JM; Allen PJ; Fong Y; Jarnagin WR; DeMatteo RP; D'Angelica MI Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S339-46. PubMed ID: 21584832 [TBL] [Abstract][Full Text] [Related]
29. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis. Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413 [TBL] [Abstract][Full Text] [Related]
30. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis. Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600 [TBL] [Abstract][Full Text] [Related]
31. Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis. Na IK; Scheibenbogen C; Adam C; Stroux A; Ghadjar P; Thiel E; Keilholz U; Coupland SE Hum Pathol; 2008 Dec; 39(12):1751-5. PubMed ID: 18701133 [TBL] [Abstract][Full Text] [Related]
32. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy. Agostini M; Pucciarelli S; Enzo MV; Del Bianco P; Briarava M; Bedin C; Maretto I; Friso ML; Lonardi S; Mescoli C; Toppan P; Urso E; Nitti D Ann Surg Oncol; 2011 Sep; 18(9):2461-8. PubMed ID: 21416156 [TBL] [Abstract][Full Text] [Related]
33. Clinical implication of CXCL12 expression in gastric cancer. Ishigami S; Natsugoe S; Okumura H; Matsumoto M; Nakajo A; Uenosono Y; Arigami T; Uchikado Y; Setoyama T; Arima H; Hokita S; Aikou T Ann Surg Oncol; 2007 Nov; 14(11):3154-8. PubMed ID: 17653799 [TBL] [Abstract][Full Text] [Related]
34. [Expression of chemokine receptor CXCR4 in colorectal carcinoma and its relationship with clinicopathological parameters]. Yu L; Shen Y; Li JK; Sun YH; Wang YC; Zhang JH Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):482-6. PubMed ID: 18803056 [TBL] [Abstract][Full Text] [Related]
35. Expression analysis of angiogenic growth factors and biological axis CXCL12/CXCR4 axis in idiopathic pulmonary fibrosis. Antoniou KM; Soufla G; Lymbouridou R; Economidou F; Lasithiotaki I; Manousakis M; Drositis I; Spandidos DA; Siafakas NM Connect Tissue Res; 2010; 51(1):71-80. PubMed ID: 20067420 [TBL] [Abstract][Full Text] [Related]
36. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma. Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128 [TBL] [Abstract][Full Text] [Related]
37. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Kang H; Mansel RE; Jiang WG Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737 [TBL] [Abstract][Full Text] [Related]
38. Gene expression in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation. Schneider S; Park DJ; Yang D; El-Khoueiry A; Sherrod A; Groshen S; Streeter O; Iqbal S; Danenberg KD; Lenz HJ Pharmacogenet Genomics; 2006 Aug; 16(8):555-63. PubMed ID: 16847424 [TBL] [Abstract][Full Text] [Related]
39. Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer. Lee YL; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Shih CM Lung Cancer; 2011 Aug; 73(2):147-52. PubMed ID: 21292343 [TBL] [Abstract][Full Text] [Related]
40. Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer. Yasuda H; Tanaka K; Saigusa S; Toiyama Y; Koike Y; Okugawa Y; Yokoe T; Kawamoto A; Inoue Y; Miki C; Kusunoki M Oncol Rep; 2009 Oct; 22(4):709-17. PubMed ID: 19724847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]